No offense taken. Never aspired for the hastily compiled list below to be 'sticky-worthy', haha. To be honest, I kind of put this together (a wee bit selfishly) for my own benefit to have jotted down in one place a quick and concise collection of all the promising potential catalysts that may come our way in the not too distant future. Certainly not the most comprehensive (or perhaps well thought out) catalogue of catalysts.
Over the course of the next 6 weeks (or so), fairly probable we will have:
1) Much awaited P21 data reported through 10th cohort.
2) 10th cohort completion and launch of super potent 11th (likely MTD).
3) Add'l Brilacidin data compiled and submitted to FDA.
4) Phase 3 B-ABSSSI meeting and trial approval.
5) Fast Track/Priority Review/5 Yr exclus. approval stemming from meeting.
6) Nasdaq Capital Market Uplisting approval and transition.
7) Stellar and reputable BOD announcements
8) B-OM trial UP and RUNNING!!!
9) Ulcerative Proctitis pre-IND FDA meeting
10) Prurisol Phase 2 Trial Commencement (unclear, but quite possible).
11) Coverage initiation (strong buy) by one or more institutional research analysts.
12) And controversially, but biggest of all, some sort of BIG PHARMA partnership deal for Brilacidin post FDA Meeting.
Among other news.
Not bad!
News 
Market Data 
Discover 
